Drug Trial Radar · NCT07625384
Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's Disease
Last checked: Nov 20, 2026Latest source record: Jun 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
52
Planned (sponsor's estimate)
Start
May 18, 2026
Primary completion
Dec 14, 2027
Study completion Jul 1, 2028
Sponsor
- Lead sponsor
- R-Pharm International, LLCIndustry
- Sponsor type
- Industry
- First posted
- Jun 4, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to evaluate the efficacy and safety of goflikicept (GFC) and olokizumab (OKZ) in patients with Still's disease
Conditions
- Still Disease
Interventions
PlaceboDrug
0.9% Sodium Chloride solution for Injection
GoflikiceptBiological
solution for subcutaneous injection and intravenous infusion, 40 mg/mL
OlokizumabBiological
solution for subcutaneous injection and intravenous infusion, 160 mg/mL
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of patients who achieved and maintained low disease activity or remission according to DAVID criteria at Day 7 (excluding the arthritis criterion) and achieved DAVID remission criteria at Day 28Time frame: Day 7 (low disease activity or remission) and Day 28 (remission)
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Republic Clinical and Diagnostic Center of the Ministry of Health of the Udmurt Republic
Izhevsk, Russia
"Vashe Zdorovie" Research Medical Complex, LLC
Kazan', Russia
Family Clinic No. 4, LLC
Korolyov, Russia
Limited Liability Company "OLLA-MED"
Moscow, Russia
State Budgetary Healthcare Institution "A.S. Loginov Moscow Clinical Scientific Center of the Moscow Department of Healthcare"
Moscow, Russia
V.A. Nasonova Research Institute of Rheumatology (Federal State Budgetary Scientific Institution)
Moscow, Russia
Limited Liability Company "Firm ORIS"
Moscow, Russia
State Budgetary Healthcare Institution of the City of Moscow "N.I. Pirogov City Clinical Hospital No. 1 of the Moscow Department of Healthcare"
Moscow, Russia
I.M. Sechenov First Moscow State Medical University, University Clinical Hospital No. 3, E.M. Tareev Clinic of Rheumatology, Nephrology and Occupational Pathology
Moscow, Russia
Russian Gerontology Clinical Research Center (RGNC) of Pirogov Russian National Research Medical University
Moscow, Russia
"Zdorovaya Semya" Medical Center
Novosibirsk, Russia
Federal Research Center "Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences"
Novosibirsk, Russia
Budgetary Healthcare Institution of the Omsk Region "Regional Clinical Hospital"
Omsk, Russia
State Budgetary Healthcare Institution "Orenburg Regional Clinical Hospital named after V.I. Voynov"
Orenburg, Russia
State Budgetary Healthcare Institution "V.A. Baranov Republican Hospital"
Petrozavodsk, Russia
Limited Liability Company "Medical Technologies"
Saint Petersburg, Russia
Interleukin LLC
Saint Petersburg, Russia
State Budgetary Healthcare Institution "Leningrad Regional Clinical Hospital"
Saint Petersburg, Russia
Limited Liability Company "Medical-Sanitary Unit No. 157" (MSU No. 157)
Saint Petersburg, Russia
State Healthcare Institution "Regional Clinical Hospital" of Saratov
Saratov, Russia
Smolensk Regional Rheumatology Center at the "RZD-Medicine" Clinical Hospital (Private Healthcare Institution)
Smolensk, Russia
Siberian State Medical University (Federal State Budgetary Educational Institution of Higher Education of the Ministry of Health of the Russian Federation)
Tomsk, Russia
State Budgetary Healthcare Institution "G.G. Kuvatov Republican Clinical Hospital"
Ufa, Russia
State Healthcare Institution "City Clinical Emergency Hospital No. 25"
Volgograd, Russia
Yaroslavl State Medical University (Federal State Budgetary Educational Institution of Higher Education of the Ministry of Health of the Russian Federation)
Yaroslavl, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.